CAR-T Therapy Effective in Youngest Kids With ALL
(MedPage Today) -- The use of tisagenlecleucel (Kymriah) in children younger than 3 years of age with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) was as effective, and safe, in a retrospective cohort study as it was previously...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Children | Hematology | Leukemia | Study